Health and Healthcare

MannKind : MNKD

All MannKind Articles

305 Articles

Chris Lange | May 25, 2018 at 9:40 AM EDT

Short Interest Remains Mixed in Major Biotechs

The May 15 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | May 10, 2018 at 10:40 AM EDT

Big Biotechs Scare Off Short Sellers

The April 30 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Apr 25, 2018 at 8:40 AM EDT

Major Biotechs Face Rising Tide of Short Interest

The April 13 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Apr 11, 2018 at 9:05 AM EDT

Short Sellers Back Way Off Major Biotechs

The March 29 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Mar 27, 2018 at 9:30 AM EDT

Major Biotechs See Rising Tide in Short Interest

The March 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Feb 28, 2018 at 4:07 PM EST

With a $1 Target Price, Is MannKind at Risk of Bankruptcy?

MannKind Corp. (NASDAQ: MNKD) has been under fire from Wall Street for quite some time and is no stranger to…

Chris Lange | Feb 28, 2018 at 9:15 AM EST

Major Biotechs Continue to See a Rising Tide of Short Interest

The short interest data are out for the most recent settlement date, February 15. Generally speaking, companies within the biotech…

Chris Lange | Feb 12, 2018 at 9:15 AM EST

Major Biotechs See Rising Tide of Short Interest

The January 31 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jan 25, 2018 at 10:05 AM EST

Short Sellers Raise the Stakes in Major Biotechs

The January 12 short interest data have been compared with the previous report, and short interest moves in the selected…

Chris Lange | Jan 11, 2018 at 9:50 AM EST

Short Sellers Grow More Selective on Major Biotechs

The December 29 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Dec 28, 2017 at 9:05 AM EST

Major Biotechs See Surge in Short Interest

The December 15 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Dec 12, 2017 at 10:10 AM EST

Major Biotechs See Rising Tide in Short Interest

The November 30 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Nov 10, 2017 at 10:40 AM EST

Short Sellers Grow More Selective on Major Biotechs

The October 31 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Oct 25, 2017 at 10:40 AM EDT

Short Sellers Chase Biotechs Higher

The October 13 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Oct 14, 2017 at 9:35 AM EDT

Top Business News of the Week: AT&T, NVIDIA, MannKind, PG&E, Walmart and Many More

24/7 Wall St. has compiled 10 of the top business news items, where there was specific company news driving the…

1 … 3 4 5 6 7 … 21

MannKind : MNKD

All MannKind Articles

Short Interest Remains Mixed in Major Biotechs

Big Biotechs Scare Off Short Sellers

Major Biotechs Face Rising Tide of Short Interest

Short Sellers Back Way Off Major Biotechs

Major Biotechs See Rising Tide in Short Interest

With a $1 Target Price, Is MannKind at Risk of Bankruptcy?

Major Biotechs Continue to See a Rising Tide of Short Interest

Major Biotechs See Rising Tide of Short Interest

Short Sellers Raise the Stakes in Major Biotechs

Short Sellers Grow More Selective on Major Biotechs

Major Biotechs See Surge in Short Interest

Major Biotechs See Rising Tide in Short Interest

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Chase Biotechs Higher

Top Business News of the Week: AT&T, NVIDIA, MannKind, PG&E, Walmart and Many More

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

MannKind : MNKD

All MannKind Articles

Short Interest Remains Mixed in Major Biotechs

Big Biotechs Scare Off Short Sellers

Major Biotechs Face Rising Tide of Short Interest

Short Sellers Back Way Off Major Biotechs

Major Biotechs See Rising Tide in Short Interest

With a $1 Target Price, Is MannKind at Risk of Bankruptcy?

Major Biotechs Continue to See a Rising Tide of Short Interest

Major Biotechs See Rising Tide of Short Interest

Short Sellers Raise the Stakes in Major Biotechs

Short Sellers Grow More Selective on Major Biotechs

Major Biotechs See Surge in Short Interest

Major Biotechs See Rising Tide in Short Interest

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Chase Biotechs Higher

Top Business News of the Week: AT&T, NVIDIA, MannKind, PG&E, Walmart and Many More

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not